Efficient Identification of Response to Cytarabine Idarubicin in Newly Diagnosed Acute Myeloid Leukemia by a New Individualized Medicine Test Based on ex vivo Pharmacology
Data de publicación
2014Título da revista
Clinical Lymphoma Myeloma & Leukemia
Tipo de contido
Publicación de congreso